Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Clin Cancer Res. 2017 Jun 20;23(19):5970–5980. doi: 10.1158/1078-0432.CCR-17-1183

Table 1.

Patient, tumor, treatment and outcome characteristics of 57 patients with fatal non anaplastic thyroid cancer

N %
Age < 45 years 5 9%
≥ 45 years 52 91%
Sex Female 32 56%
Male 25 44%
pT size ≤ 4 cm 22 39%
> 4 cm 32 56%
Unknown 3 5%
pT stage T1 2 4%
T2 0 0%
T3 19 32%
T4 34 60%
TX 2 4%
ETE No 9 15%
Yes 46 81%
  microscopic 12 21%
  gross 34 60%
Unknown 2 4%
Margins Negative 25 44%
Positive/Close 30 52%
Unknown 2 4%
pN stage N0/Nx 25 44%
N1a 8 14%
N1b 23 40%
Unknown 1 2%
M stage M0 27 47%
M1 30 53%
Stage 1 3 5%
2 0 0%
3 5 9%
4 47 82%
Unknown 2 4%
Tm grade PDTC 35 61%
WDTC 22 39%

ETE extrathyroid extension

pNx clinically negative neck